FDA 483 - Cantor BioConnect, Inc. - March 24, 2026

Cantor BioConnect, Inc., a blood component storage and distribution facility in Santee, CA, received a Form 483 with two observations. The inspection revealed deficiencies in the firm's complaint handling system for distributed biological products and a failure to conduct preventive maintenance on -20°C freezers according to manufacturer specifications. These issues indicate a need for improved quality system procedures and equipment management.